Monashee Investment Management LLC Fate Therapeutics Inc Transaction History

Monashee Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$30.41 - $40.5 $2.74 Million - $3.65 Million	-90,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$20.21 - $35.23 $1.82 Million - $3.17 Million	90,000 New	90,000 $3.09 Million
Q4 2019 Feb 12, 2020	SELL	$13.39 - $20.73 $1.34 Million - $2.07 Million	-99,900 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$15.47 - $22.5 $1.55 Million - $2.25 Million	99,900 New	99,900 $1.55 Million
Q4 2018 Feb 12, 2019	SELL	$11.48 - $16.98 $1.85 Million - $2.73 Million	-160,986 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$8.75 - $16.29 $1.41 Million - $2.62 Million	160,986 New	160,986 $2.62 Million
Q1 2018 May 10, 2018	SELL	$6.3 - $13.77 $1.89 Million - $4.13 Million	-300,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.94 - $6.64 $1.18 Million - $1.99 Million	300,000	300,000 $1.83 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $235M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.